James E. Finley

994 total citations
11 papers, 535 citations indexed

About

James E. Finley is a scholar working on Oncology, Molecular Biology and Physiology. According to data from OpenAlex, James E. Finley has authored 11 papers receiving a total of 535 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 3 papers in Molecular Biology and 3 papers in Physiology. Recurrent topics in James E. Finley's work include Drug Transport and Resistance Mechanisms (3 papers), Alzheimer's disease research and treatments (3 papers) and Computational Drug Discovery Methods (2 papers). James E. Finley is often cited by papers focused on Drug Transport and Resistance Mechanisms (3 papers), Alzheimer's disease research and treatments (3 papers) and Computational Drug Discovery Methods (2 papers). James E. Finley collaborates with scholars based in United States and Japan. James E. Finley's co-authors include Charles E. Nolan, K. Richter, Joel B. Schachter, Lit‐Fui Lau, Mathieu Herman, Pavan Krishnamurthy, Karen Duff, Robert B. Nelson, Wen Yi and Lili Wang and has published in prestigious journals such as Journal of Neuroscience, Journal of Pharmacology and Experimental Therapeutics and Toxicology and Applied Pharmacology.

In The Last Decade

James E. Finley

11 papers receiving 525 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
James E. Finley United States	7	277	150	129	124	115	11	535
Nadège Zommer France	8	538 1.9×	257 1.7×	272 2.1×	142 1.1×	116 1.0×	10	819
Xiaoqin Run China	12	338 1.2×	292 1.9×	155 1.2×	128 1.0×	60 0.5×	16	725
Jillian C. Belrose Canada	10	138 0.5×	192 1.3×	106 0.8×	95 0.8×	26 0.2×	16	658
Katsuji Kobayashi Japan	14	333 1.2×	247 1.6×	153 1.2×	37 0.3×	58 0.5×	36	700
Rui Lu China	13	120 0.4×	158 1.1×	76 0.6×	70 0.6×	61 0.5×	26	395
Bingrui Xiong China	16	282 1.0×	184 1.2×	152 1.2×	68 0.5×	39 0.3×	22	642
Franck R. Petry Canada	10	257 0.9×	126 0.8×	144 1.1×	40 0.3×	37 0.3×	13	474
Vesna Tešić United States	15	128 0.5×	172 1.1×	136 1.1×	141 1.1×	15 0.1×	36	549
Jing‐Ru Hao China	10	106 0.4×	105 0.7×	111 0.9×	80 0.6×	59 0.5×	21	369
Xuehai Guan China	15	416 1.5×	139 0.9×	195 1.5×	37 0.3×	71 0.6×	25	710

Countries citing papers authored by James E. Finley

Since Specialization

Citations

This map shows the geographic impact of James E. Finley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James E. Finley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James E. Finley more than expected).

Fields of papers citing papers by James E. Finley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James E. Finley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James E. Finley. The network helps show where James E. Finley may publish in the future.

Co-authorship network of co-authors of James E. Finley

This figure shows the co-authorship network connecting the top 25 collaborators of James E. Finley. A scholar is included among the top collaborators of James E. Finley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James E. Finley. James E. Finley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Qiu, Luping, Steven W. Kumpf, Elias M. Oziolor, et al.. (2025). In vitro NIH3T3 mouse embryonic fibroblast cell model does not predict AAV2 or AAVdj-mediated cell transformation. Toxicology and Applied Pharmacology. 495. 117229–117229. 2 indexed citations

Kopec, Anna K., Ryuji Yokokawa, Nasir Khan, et al.. (2021). Microphysiological systems in early stage drug development: Perspectives on current applications and future impact. The Journal of Toxicological Sciences. 46(3). 99–114. 22 indexed citations

Finley, James E., Anna K. Kopec, Petra Koza‐Taylor, et al.. (2020). An in vitro alveolar epithelial cell model recapitulates LRRK2 inhibitor-induced increases in lamellar body size observed in preclinical models. Toxicology in Vitro. 70. 105012–105012. 6 indexed citations

Finley, James E., et al.. (2017). Development of Fluorophore-Labeled Thailanstatin Antibody-Drug Conjugates for Cellular Trafficking Studies. Bioconjugate Chemistry. 28(4). 1041–1047. 13 indexed citations

Qiu, Luping, James E. Finley, Mohammed Taimi, et al.. (2015). High-Content Imaging in Human and Rat Hepatocytes Using the Fluorescent Dyes CLF and CMFDA Is Not Specific Enough to Assess BSEP/Bsep and/or MRP2/Mrp2 Inhibition by Cholestatic Drugs. 1(3). 198–212. 6 indexed citations

Lanz, Thomas A., Kathleen M. Wood, K. Richter, et al.. (2010). Pharmacodynamics and Pharmacokinetics of the γ-Secretase Inhibitor PF-3084014. Journal of Pharmacology and Experimental Therapeutics. 334(1). 269–277. 39 indexed citations

Kleiman, Robin J., Thomas A. Lanz, James E. Finley, et al.. (2010). P3‐380: Dendritic spine density deficits in the hippocampal CA1 region of young Tg2576 mice are ameliorated with the PDE9A inhibitor PF‐04447943. Alzheimer s & Dementia. 6(4S_Part_18). 12 indexed citations

Wood, Kathleen M., Thomas A. Lanz, Karen J. Coffman, et al.. (2008). P2‐375: Efficacy of the novel γ‐secretase inhibitor, PF‐3084014, in reducing Aβ in brain, CSF, and plasma in guinea pigs and Tg2576 mice. Alzheimer s & Dementia. 4(4S_Part_14). 11 indexed citations

Planel, Emmanuel, K. Richter, Charles E. Nolan, et al.. (2007). Anesthesia Leads to Tau Hyperphosphorylation through Inhibition of Phosphatase Activity by Hypothermia. Journal of Neuroscience. 27(12). 3090–3097. 312 indexed citations

10.

Corwin, Jeffrey T., Mark E. Warchol, Linda D. Saffer, et al.. (2007). Growth Factors as Potential Drugs for the Sensory Epithelia of the Ear. Novartis Foundation symposium. 196. 167–187. 5 indexed citations

11.

Lanz, Thomas A., Michael J. Karmilowicz, Kathleen M. Wood, et al.. (2006). Concentration-Dependent Modulation of Amyloid-β in Vivo and in Vitro Using the γ-Secretase Inhibitor, LY-450139. Journal of Pharmacology and Experimental Therapeutics. 319(2). 924–933. 107 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact